Skip to main content
. 2022 Oct 17;75:10–18. doi: 10.1016/j.jelectrocard.2022.10.005

Table 3.

The adjusted association between abnormal ECG and ICU/in-hospital death within 30 days.

Variable OR (95%CI) p-value
Univariable 2.03 (1.20–3.46) 0.0094
Model Aa 2.13 (1.22–3.74) 0.0081
Model Bb 2.04 (1.16–3.62) 0.014
Model Cc 2.80 (1.20–6.70) 0.018
Model Dd 2.11 (1.21–3.66) 0.0084

Baseline variables = Age, sex, body mass index; history of diabetes, hypertension, hyperlipidaemia, ischemic heart disease, heart failure, atrial fibrillation, peripheral artery disease, chronic obstructive pulmonary disease, asthma and chronic kidney failure; prior acute myocardial infarction, stroke and venous thromboembolism; active cancer, any dementia, smoking; pre-admission treatment with beta-blockers, anti-arrhythmic agents, digoxin, aspirin, warfarin, direct-acting oral anti coagulants, angiotensin converting enzyme inhibitors, angiotensin receptor blockers, calcium antagonists, statins, P2Y12 inhibitors, mineralocorticoid receptor antagonists, diuretics, oral antidiabetics and oral cortisone; admission blood pressure, heart rate, respiratory rate and saturation without oxygen; oxygen at admission, admission cycle threshold value; presenting with fever, cough, dyspnea, sore throat, nasal congestion, loss of smell, loss of taste, headache, chest pain, abdominal pain, vomiting, diarrhea and disorientation.

a

Adjusted for age and sex.

b

Adjusted for age, sex, diabetes and hypertension.

c

Propensity score adjusted for all baseline variables.

d

Propensity score weighted with all baseline variables.